Zacks Investment Research upgraded shares of Tate & Lyle (OTCMKTS:TATYY) from a strong sell rating to a hold rating in a research note published on Tuesday.
According to Zacks, “Tate & Lyle Ventures and Agri Investment Fund have co-led a 3.5m investment into Fugeia, a newly formed functional food technology business with a focus on gut health. “
Several other brokerages have also commented on TATYY. Societe Generale raised shares of Tate & Lyle from a hold rating to a buy rating in a research report on Friday, February 9th. Kepler Capital Markets raised shares of Tate & Lyle from a hold rating to a buy rating in a research report on Tuesday, February 13th. Finally, ValuEngine lowered shares of Tate & Lyle from a buy rating to a hold rating in a research report on Monday, April 2nd. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company has an average rating of Hold and an average price target of $42.00.
Shares of Tate & Lyle stock opened at $31.65 on Tuesday. The company has a market capitalization of $3,677.08, a P/E ratio of 12.62, a P/E/G ratio of 6.42 and a beta of 0.40. Tate & Lyle has a 52 week low of $29.39 and a 52 week high of $42.20.
ILLEGAL ACTIVITY NOTICE: This piece was first published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.thelincolnianonline.com/2018/04/20/tate-lyle-tatyy-lifted-to-hold-at-zacks-investment-research.html.
Tate & Lyle Company Profile
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through two segments, Speciality Food Ingredients and Bulk Ingredients.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.